ResearcherUniversity of MichiganNo recent work listed
Ines Lohse
Matched on ORCID iD 0000-0002-9979-9400; OpenAlex author ID A5040797685. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2015: 2 papers · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 2 papers
Papers 8
- Pathogenesis and Treatment of Pancreatic Cancer Related Pain. Co-author DOI 10.21873/anticanres.14133↗
- Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Persona… First author DOI 10.3390/cancers12041011↗
- Naturally occurring compounds as pancreatic cancer therapeutics. Co-author DOI 10.18632/oncotarget.26234↗
- Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chemoradiotherapy. First author DOI 10.1021/acs.jproteome.7b00024↗
- Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts. Co-author DOI 10.18632/oncotarget.13619↗
- Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer Xenografts. Co-author DOI 10.1371/journal.pone.0167272↗
- BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts. Co-author DOI 10.1038/bjc.2015.220↗
- Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Co-author DOI 10.1038/nm.3973↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shaun P. Brothers · 2 shared papers, 2018–2020 · strength 0.37
- David William Hedley · 3 shared papers, 2015–2017 · strength 0.19
- Paper Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts. DOI 10.18632/oncotarget.13619↗
- Paper Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Pati… DOI 10.1371/journal.pone.0167272↗
- Paper BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts. DOI 10.1038/bjc.2015.220↗
- Theodore Steven Lawrence · 2 shared papers, 2017–2020 · strength 0.17
- Paper Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenog… DOI 10.3390/cancers12041011↗
- Paper Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chem… DOI 10.1021/acs.jproteome.7b00024↗
- Meredith Ann Morgan · 2 shared papers, 2017–2020 · strength 0.17
- Paper Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenog… DOI 10.3390/cancers12041011↗
- Paper Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chem… DOI 10.1021/acs.jproteome.7b00024↗
- Kyle Clifford Cuneo · 2 shared papers, 2017–2020 · strength 0.17
- Paper Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenog… DOI 10.3390/cancers12041011↗
- Paper Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chem… DOI 10.1021/acs.jproteome.7b00024↗
- Steve Gallinger · 3 shared papers, 2015–2016 · strength 0.15
- Paper Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Pati… DOI 10.1371/journal.pone.0167272↗
- Paper BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts. DOI 10.1038/bjc.2015.220↗
- Paper Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organ… DOI 10.1038/nm.3973↗
- Lianette Rivera-Báez · 1 shared paper, 2020 · strength 0.10
- Sarah Owen · 1 shared paper, 2020 · strength 0.10
- Sunitha Nagrath · 1 shared paper, 2020 · strength 0.10
- Ming‐Sound Tsao · 2 shared papers, 2015 · strength 0.08
- Mingrui An · 1 shared paper, 2017 · strength 0.07
- Zhijing Tan · 1 shared paper, 2017 · strength 0.07
- David M. Lubman · 1 shared paper, 2017 · strength 0.07
- Jianhui Zhu · 1 shared paper, 2017 · strength 0.07
- Ayelet Borgida · 1 shared paper, 2015 · strength 0.04
- Ling Huang · 1 shared paper, 2015 · strength 0.04
- Sean Patrick Cleary · 1 shared paper, 2015 · strength 0.04
- Ashton Anthony Connor · 1 shared paper, 2015 · strength 0.04
- Steve E. Kalloger · 1 shared paper, 2015 · strength 0.04
- David F. Schaeffer · 1 shared paper, 2015 · strength 0.04
- Michael H. A. Roehrl · 1 shared paper, 2015 · strength 0.04
- Daniel John Renouf · 1 shared paper, 2015 · strength 0.04
- Senthil K. Muthuswamy · 1 shared paper, 2015 · strength 0.04
- Howard C. Crawford · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.